Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Annah S. Rolig"'
Autor:
Elizabeth R. Sturgill, Annah S. Rolig, Stefanie N. Linch, Courtney Mick, Melissa J. Kasiewicz, Zhaoyu Sun, Peter G. Traber, Harold Shlevin, William L. Redmond
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Treatment with an agonist anti-OX40 antibody (aOX40) boosts anti-tumor immunity by providing costimulation and driving effector T cell responses. However, tumor-induced immune suppression contributes significantly to poor response rates to aOX40 ther
Externí odkaz:
https://doaj.org/article/161b14a5b58c4b3baa656311843a52b3
Publikováno v:
OncoImmunology, Vol 7, Iss 6 (2018)
The efficacy of cancer immunotherapy is limited, in part, by the multitude of immunosuppressive mechanisms present within the tumor microenvironment (TME). Galectin-3 (Gal-3) is a lectin that contributes to TME immunosuppression and regulates diverse
Externí odkaz:
https://doaj.org/article/cb05e67eabd04b63851ec57d667f5590
Autor:
Matthew Jemielita, Michael J. Taormina, Adam R. Burns, Jennifer S. Hampton, Annah S. Rolig, Karen Guillemin, Raghuveer Parthasarathy
Publikováno v:
mBio, Vol 5, Iss 6 (2014)
ABSTRACT The vertebrate intestine is home to microbial ecosystems that play key roles in host development and health. Little is known about the spatial and temporal dynamics of these microbial communities, limiting our understanding of fundamental pr
Externí odkaz:
https://doaj.org/article/b8905efcac6b412cbd8e48a8e58cfb79
Publikováno v:
Bioanalysis.
Previously designed flow cytometry panels have provided a framework to analyze T-cell activation; however, few provide an extensive view of lymphocyte populations, and none are optimized for murine models. This article describes a panel designed spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0c58827ccbef88c2bc59fef5f4b6f43
https://doi.org/10.4155/bio-2023-0005
https://doi.org/10.4155/bio-2023-0005
Autor:
Scott W. Rowlinson, William L. Redmond, James E. Wooldridge, Venkatesh Rajamanickam, Matthew G. Vander Heiden, Christopher Daige, Jessica Van Cleef, Mark R. Sullivan, Alexander Muir, Jason F. Wiggins, Leslie Priddy, Melissa J. Kasiewicz, Danlee Enzler, Giulia Agnello, Annah S. Rolig, Mark D. Badeaux
Supplemental Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c374fbe52a70f3b6c21dfd4413f5e202
https://doi.org/10.1158/2326-6066.22543186.v1
https://doi.org/10.1158/2326-6066.22543186.v1
Autor:
Scott W. Rowlinson, William L. Redmond, James E. Wooldridge, Venkatesh Rajamanickam, Matthew G. Vander Heiden, Christopher Daige, Jessica Van Cleef, Mark R. Sullivan, Alexander Muir, Jason F. Wiggins, Leslie Priddy, Melissa J. Kasiewicz, Danlee Enzler, Giulia Agnello, Annah S. Rolig, Mark D. Badeaux
Supplemental Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e4149fe9d1a33baee87cf325285d4d
https://doi.org/10.1158/2326-6066.22543189.v1
https://doi.org/10.1158/2326-6066.22543189.v1
Autor:
Scott W. Rowlinson, William L. Redmond, James E. Wooldridge, Venkatesh Rajamanickam, Matthew G. Vander Heiden, Christopher Daige, Jessica Van Cleef, Mark R. Sullivan, Alexander Muir, Jason F. Wiggins, Leslie Priddy, Melissa J. Kasiewicz, Danlee Enzler, Giulia Agnello, Annah S. Rolig, Mark D. Badeaux
Supplementary Figure and Table Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28cf8606f1eb09167bed4e697d20820b
https://doi.org/10.1158/2326-6066.22543183
https://doi.org/10.1158/2326-6066.22543183
Legends for Supplementary Figures 1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e5679943ad02590ca52cae4fbe1fba
https://doi.org/10.1158/2326-6066.22543261
https://doi.org/10.1158/2326-6066.22543261
Supplemental Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8650b4a9a05363c7286d8fcc75b016a5
https://doi.org/10.1158/2326-6066.22543258.v1
https://doi.org/10.1158/2326-6066.22543258.v1
CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models. We have shown previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6550f4b330c1650043a954fa869e9b
https://doi.org/10.1158/2326-6066.c.6550189.v1
https://doi.org/10.1158/2326-6066.c.6550189.v1